B-cell lymphoma clinical trials now open on the TrialWire Platform

ADELAIDE, AUS, Jan 5, 2022 - (ACN Newswire) - TrialWire is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire

Related Keywords

Australia ,New Zealand ,Adelaide ,South Australia ,Kostenloser Wertpapierhandel ,Salesforce Health Cloud ,Salesforce Health ,Study Coordinators ,Wire Platform ,Wire Study Dashboards ,Cell ,Lymphoma ,Linical ,Trials ,Pen ,Trialwire ,Platform ,